共 24 条
[1]
2014年中国胆固醇教育计划血脂异常防治专家建议[J] 2014年中国胆固醇教育计划血脂异常防治建议专家组;中华心血管病杂志编辑委员会;血脂与动脉粥样硬化循证工作组;中华医学会心血管病学分会流行病学组; 中华心血管病杂志 2014, 08
[3]
慢性稳定性心绞痛诊断与治疗指南[J] 中华心血管病杂志 2007, 03
[4]
2013 ESC guidelines on the management of stable coronary artery disease[J] Gilles Montalescot;Udo Sechtem;Stephan Achenbach;Felicita Andreotti;Chris Arden;Andrzej Budaj;Raffaele Bugiardini;Filippo Crea;Thomas Cuisset;Carlo Di Mario;J. Rafael Ferreira;Bernard J. Gersh;Anselm K. Gitt;Jean-Sebastien Hulot;Nikolaus Marx;Lionel H. Opie;Matthias Pfisterer;Eva Prescott;Frank Ruschitzka;Manel Sabaté;Roxy Senior;David Paul Taggart;Ernst E. van der Wall;Christiaan J.M. Vrints;Jose Luis Zamorano;Stephan Ac
[5]
Simvastatin impairs exercise training adaptations[J] Catherine R. Mikus;Leryn J. Boyle;Sarah J. Borengasser;Douglas J. Oberlin;Scott P. Naples;Justin Fletcher;Grace M. Meers;Meghan Ruebel;M. Harold Laughlin;Kevin C. Dellsperger;Paul J. Fadel;John P. Thyfault Journal of the American College of Cardiology 2013,
[6]
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines; and the American College of Physicians; American Association for Thoracic Surgery; Preventive Cardiovascular Nurses Association; Society for Cardiovascular Angiography and Interventions; and Society of[J] Stephan D. Fihn;Julius M. Gardin;Jonathan Abram
[7]
Ten-year outcomes of patients randomized to surgery; angioplasty; or medical treatment for stable multivessel coronary disease: Effect of age in the Medicine; Angioplasty; or Surgery Study II trial[J] Paulo Cury Rezende;Whady Hueb;Cibele Larrosa Garzillo;Eduardo Gomes Lima;Alexandre Ciappina Hueb;José Antonio Franchini Ramires;Roberto Kalil Filho The Journal of Thoracic and Cardiovascular Surgery 2012,
[8]
Management of stable angina: summary of NICE guidance.[J] Henderson Robert A;O'Flynn Norma Heart (British Cardiac Society) 2012,
[9]
Use of secondary prevention drugs for cardiovascular disease in the community in high-income; middle-income; and low-income countries (the PURE Study): a prospective epidemiological survey[J] Salim Yusuf;Shofiqul Islam;Clara K Chow;Sumathy Rangarajan;Gilles Dagenais;Rafael Diaz;Rajeev Gupta;Roya Kelishadi;Romaina Iqbal;Alvaro Avezum;Annamarie Kruger;Raman Kutty;Fernando Lanas;Liu Lisheng;Li Wei;Patricio Lopez-Jaramillo;Aytekin Oguz;Omar Rahman;Hany Swidan;Khalid Yusoff;Witold Zatonski;Annika Ros
[10]
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update[J] Sidney C. Smith;Emelia J. Benjamin;Robert O. Bonow;Lynne T. Braun;Mark A. Creager;Barry A. Franklin;Raymond J. Gibbons;Scott M. Grundy;Loren F. Hiratzka;Daniel W. Jones;Donald M. Lloyd-Jones;Margo Minissian;Lori Mosca;Eric D. Peterson;Ralph L. Sacco;John Spertus;James H. Stein;Kathryn A. Taubert Journal of the American College of Cardiology 2011,